NCT07190482View on ClinicalTrials.gov

Treatment of Tinnitus With Olanzapine

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

December 20, 2024

Study Completion Date

January 20, 2025

Conditions
TinnitusTinnitus, Subjective
Interventions
DRUG

Olanzapine 5 Mg ORAL TABLET

OLANZAPINE ARM

DRUG

Placebo Drug

placebo administered for 8 weeks

Trial Locations (1)

05403000

Research Ethics Committee (CEP), São Paulo

All Listed Sponsors
lead

University of Sao Paulo

OTHER

NCT07190482 - Treatment of Tinnitus With Olanzapine | Biotech Hunter | Biotech Hunter